R&D Why it is more important than ever to optimise and innovate ... Rare disease research is vital to improve the lives of hundreds of millions of people worldwide.
R&D How the Life Sciences Innovative Manufacturing Fund can boos... Since the turn of the decade, the pharmaceuticals industry has dealt with supply chain challenges caused by both the pandemic and global conflict.
News NHS "isn't delivering equitable care for rare diseases" A Genetic Alliance UK report claims the NHS is failing to meet the needs of many of the 3.5 million people in the country who live with rare diseases.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
